ALL blasts do not express asparagine synthase which synthesizes the essential aminoacid asparagin, and are thus are susceptible to treatment to the drug L-asparaginase which inhibits asparagine synthase and further depletes this aminoacid rendering the blasts vulnerable [243]. This evidence concerns the gene ASPG and acute lymphoblastic leukemia.